XML 37 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Underwritten Public Offering [Member]
ATM [Member]
Preferred Stock [Member]
Preferred Stock [Member]
Series A Non-Voting Convertible Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Underwritten Public Offering [Member]
Common Stock [Member]
ATM [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Underwritten Public Offering [Member]
Additional Paid-in Capital [Member]
ATM [Member]
Accumulated Other Comprehensive (Income) Loss [Member]
Accumulated Deficit [Member]
Beginning Balances at Dec. 31, 2020 $ 234,667     $ 110,881   $ 32     $ 322,454       $ (198,700)
Beginning Balances, Shares at Dec. 31, 2020       132,244   32,347,905              
Conversion of preferred stock into common stock         $ (25,481) $ 8     25,473        
Conversion of preferred stock into common stock, Shares         (28,955) 7,238,750              
Issuance of common stock for services 260               260        
Issuance of common stock for services, Shares           31,683              
Issuance of common stock upon exercise of stock options 24               24        
Issuance of common stock upon exercise of stock options, Shares           15,758              
Issuance of common stock under Employee Stock Purchase Plan 31               31        
Issuance of common stock under Employee Stock Purchase Plan, shares           4,497              
Issuance of common stock, net of issuance costs     $ 38,006         $ 4     $ 38,002    
Issuance of common stock, net of issuance costs, Shares               3,954,900          
Issuance of common stock to settle CVR liability 2,043               2,043        
Issuance of common stock to settle CVR liability, Shares           212,429              
Stock-based compensation expense 11,426               11,426        
Net loss (72,273)                       (72,273)
Ending Balances at Dec. 31, 2021 214,184       $ 85,400 $ 44     399,713       (270,973)
Ending Balances, Shares at Dec. 31, 2021         103,289 43,805,922              
Conversion of preferred stock into common stock         $ (19,570) $ 6     19,564        
Conversion of preferred stock into common stock, Shares         (22,239) 5,559,750              
Issuance of common stock upon exercise of stock options 1,238               1,238        
Issuance of common stock upon exercise of stock options, Shares           154,822              
Issuance of common stock under Employee Stock Purchase Plan 351               351        
Issuance of common stock under Employee Stock Purchase Plan, shares           49,000              
Issuance of common stock, net of issuance costs   $ 161,915         $ 18     $ 161,897      
Issuance of common stock, net of issuance costs, Shares             17,899,698            
Pre-funded warrant exercise 24         $ 2     22        
Pre-funded warrant exercise, shares           2,424,242              
Unrealized gains (losses) on marketable securities (104)                     $ (104)  
Stock-based compensation expense 18,368               18,368        
Net loss (140,241)                       (140,241)
Ending Balances at Dec. 31, 2022 255,735       $ 65,830 $ 70     601,153     (104) (411,214)
Ending Balances, Shares at Dec. 31, 2022         81,050 69,893,434              
Conversion of preferred stock into common stock         $ (5,795) $ 2     5,793        
Conversion of preferred stock into common stock, Shares         (6,585) 1,646,250              
Issuance of common stock upon exercise of stock options 965               965        
Issuance of common stock upon exercise of stock options, Shares           123,687              
Issuance of common stock under Employee Stock Purchase Plan 752               752        
Issuance of common stock under Employee Stock Purchase Plan, shares           85,878              
Issuance of common stock, net of issuance costs   $ 161,789         $ 14     $ 161,775      
Issuance of common stock, net of issuance costs, Shares             14,375,000            
Unrealized gains (losses) on marketable securities 350                     350  
Stock-based compensation expense 30,621               30,621        
Net loss (192,410)                       (192,410)
Ending Balances at Dec. 31, 2023 $ 257,802       $ 60,035 $ 86     $ 801,059     $ 246 $ (603,624)
Ending Balances, Shares at Dec. 31, 2023         74,465 86,124,249